by Elizabeth Kissling | Aug 4, 2011 | Health Care, New Research, Pharmaceutical
Successful tests on rhesus monkeys are a long way from clinical trials on women, but this is interesting to those of us following the conversations and debates about cycle-stopping contraceptives: new research testing progestin antagonists indicates that the drug can...
by Elizabeth Kissling | Feb 8, 2011 | Law/Legal, Menopause, Pharmaceutical
Pfizer, which now owns Wyeth’s PremPro synthetic progestin-estrogen combination that was widely taken for relief of discomforts that sometimes accompany menopause, has been ordered to pay damages in two separate cases this week. The company must pay more than...
by Elizabeth Kissling | Jan 27, 2011 | Anatomy, Menstruation, New Research, Pharmaceutical
Guest Post by Emily Swan, Marymount Manhattan College With the military’s history of suppressing minority groups, its new effort to conceal and terminate menstruation comes as no surprise. Hopefully, the menses will be able to come out of the closet soon enough. I...
by Elizabeth Kissling | Jan 24, 2011 | Advertising, Media, Menorrhagia, Menstruation, Pharmaceutical, Television
The US Food and Drug Administration (FDA) approved tranexamic acid tablets as treatment for heavy menstrual bleeding more than a year ago, but you probably haven’t seen much of this television commercial to promote the drug (brand name Lysteda). Matthew Arnold...
by Elizabeth Kissling | Jan 13, 2011 | Birth Control, Menstruation, New Research, Pharmaceutical
One of the arguments for using hormonal contraception to suppress the menstrual cycle is that it mitigates the logistical challenges menstruation can present in high-stress occupations in harsh settings — such as military service in a combat theatre. Given how ...
by Elizabeth Kissling | Dec 29, 2010 | Activism, Pharmaceutical
Guest post by Leslie Botha, S.A.N.E. Vax Increasing Number of Consumers are Concerned over HPV Vaccine Safety The FDA’s December 22, 2010 ruling to expand the use of Gardasil for anal cancer prevention is unacceptable, according to Norma Erickson, President of S.A.N.E...
